Conference Series LLC like to take this opportunity to welcome all of you to “8th International Conference on Proteomics & Bioinformatics” which is to be held during May 22-24, 2017 at Osaka, Japan. Through our theme ‘Proteomics & Bioinformatics: Solving Problems in Health and Life Sciences’, the conference will analyze the recent advancements and new modes that can be enforced to the research to take Proteomics, one step further.
Japan is the second largest Life science market in the world after USA, Occupying about 10% of Market in each of the global drug and Medical devices market. According to Data monitor, the Japanese biotechnology market had total revenue of $ 43.3 Billion in 2013. By 2017, the market is expected to grow to $ 53.8 Billion.
The Japanese pharmaceutical market is the world’s second-largest, with 2013 sales estimated at $115 billion. Japan accounts for a little less than 10 percent of the global Pharma market, compared with 38.4 percent for the U.S. and 20.7 percent for Western Europe
The Japanese market is a promising region for proteomics companies, as a high amount of proteomics research is being conducted in the country.
Website link: http://www.proteomicsconference.com/asia-pacific/
Submit your abstract at: http://www.proteomicsconference.com/asia-pacific/abstract-submission.php
For more details: proteomicsasia@biochemconferences.org
No comments:
Post a Comment